On Friday, Pharmaceuticals company Divis Laboratories reported a 26% rise in its consolidated net profit at ₹702 crore as compared to ₹557 crore in the same quarter last year. Meanwhile, its revenue from operations rose about 15% to ₹2,254 crore from ₹1,960.6 crore year-on-year (YoY).
Profit before tax (PBT) came in at ₹851 crore, up 4.5% over ₹814 crore in the year-ago quarter. Divi’s Labs forex gain in Q1 FY23 rose to ₹56 crore as against the gain of ₹20 crore in Q1 FY22. It witnessed a rise in tax expense at ₹149 crore from ₹257 crore (YoY).